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ABSTRACT
Objective: To determine the lipid profile complete blood count and other biochemical
parameters in normotensive and hypertensive individuals.
Design: Cross-sectional population-based epidemiological household survey.
Setting: Population sample of the Eastern Province of Saudi Arabia.
Results: Hypertensive individuals had significantly higher mean levels of glucose, Tc,
LDL-c, HDL-c, triglycerides and HBAIc, compared to normotensive individuals while
there were no significant difference in the mean levels of Apo AI and Apo B. Within
the same group there were variations in the levels of certain parameters between male
and female. While the mean levels of haemoglobin, WBC and platelets were significantly
higher in the hypertensive group compared to normotensive, there were no significant
differences between these two groups in the levels of RBC, MCV, HCT, MCH and
MCHC. However, the mean levels haemoglobin, RBC count and HCT were significantly
higher in male compared to female within the same group with no significant difference
in levels of WBC, MCV, MCH and MCHC. Furthermore, the mean concentration of
platelets was significantly higher in females compared to male within the same group.
Hypertensive individuals had significantly higher serum sodium, chloride and calcium
levels but a significantly lower potassium level when compared to normotensive with
no siginificant differences between male and female within the same group.
Conclusion: The lipid and electrolyte profile of hypertensive individuals differ from that
of normotensive individuals in this population. This study has contributed towards
establishing the normal values for a number of parameters involved in the aetiology
of cardiovascular diseases in the population of Eastern province.
INTRODUCTION
Cardiovascular disease (CVD) is the leading cause
of illness in the industrial world and its incidence is
progressively increasing in the developing countries(1).
Hypertension is the most important risk factor of CVD
which increases the risk of stroke, myocardial infarction,
heart and renal failure. Coronary atherosclerosis is the
result of complex processes which include inflammatory
processes, low density lipoprotein (LDL) accumulation
and smooth muscle cell migration (2). These processes
at different degrees are modulated by many factors
including hypertension, diabetes and smoking (3). It has
well been established that high blood LDL cholesterol
(LDL-c) among others, is associated with the early
development of atheroselerotic plaques. An increase of
one standard deviation for every LDL cholesterol
concentration has been shown to be associated with
5.4% more atherosclerotic lesions (4). Additionally,
biochemical research has provided evidence that LDL
cholesterol promotes atherosclerotic calcification of
vascular cells due to products of lipid oxidation (5).
A number of studies have reported a progressive
increase in the incidence of CVDs in the Mediterranean
region including Saudi Arabia (6,7). This has been
attributed to the tremendous changes in socio-economic
factors and the life style of these populations. This
changing life style and technology of the modern
nvironment which brings with them diminished
physical activity, abundance of high energy and dense
food in combination with social stresses and deleterious
habits in populations unaccustoned to such exposure
are leading to increasing occurence of CVDs. Yet,
clinical trials have provided compelling evidence that
coronary heart disease is largely preventable (8).
However the efficiency and success of the above
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measures depend on previous identification of the
population risk factors.
There have been many studies in the kingdom of
Saudi Arabia concerning hypertension and other risk
factors, with varied results and conclusion (9-14). This
may reflect the non uniformity of the study design
populations surveyed and different laboratory procedures.
In addition many of the studies are hospital based (15).
The present study was carried out to establish the
local norms and identify the risk factors in the
communities of the Eastern Province as part of a
comprehensive population based study of hypertension.
MATERIALS AND METHODS
During a household screening programme of hypertension
in the Eastern province of Saudi Arabia, 250 hypertensive
Saudi males and females aged 18-60 and similar numbers of
controls were randomly selected. The section was from a
sample of 6000 representing the population of Eastern Province
with all its socio-economical and genetic variabilities. A written
informed consent was obtained from each subject. Extreme care
was taken in the random selection of hypertensive and control
groups to ensure that they represented a broad cross sectional
coverage of all population in the Eastern Province. The control
group consisted of healthy volunteers who were not taking
hormones or drugs known to affect plasma lipid levels.
Hypertension was considered to be present if subjects met the
following criteria: Systolic pressure of 140mmHg and above
and diastolic pressure of 90mmHg and above on two occasions
by the same interviewer (1). Blood samples were obtained at
the local primary health centre after an overnight fast. Blood
pressure measurements were obtained using a mercury
sphygmomanometer on three occations during the interview.
Blood collected in red top vacutainer tubes was allowed to
stand for 30 minutes at room temperature to allow complete
clotting and clot retraction. Samples were centrifuged at 2000
x g for 15 min, divided into aliquots and stored at -20° celsius.
Three millilitres of blood was collected in EDTA coated tubes
and 4ml of blood was collected in plain tubes. Haematological
indices were determined for all samples using a haematological
analyzer (ACT-8 coulter Electronies). Glucose, creatinine,
BUN, uric acid, Tc, HDL-c and triglycerides were determined
as previously described (17-19). LDL-c was calculated using
the Friedwald formula (20). Apo A-I and Apo B were
determined by ELIZA methods while HBAI-c was determined
by affinity chromatography (Bio Merieux Sa,
Immunoturbidimetric assay of Apo A-I and Apo B, Helena
GLYCO-TEK Affinity Column). Serum sodium, potassium,
chloride and calcium were determined using electrolyte analyzer
(AVL 9180 Electrolyte analyzer). Mean values in lipid
lipoproteins and other parameters between subgroups were
compared using the independent sample t-test. All statistical
analyses were perfomed using the SPSS package (version 10).
A p-value of <0.05 was considered to be statistically significant.
Quality control procedures included the re-analysis of 5% of
frozen specimens randomly selected either within assay or
between assays.
RESULTS
The mean values of blood indices are presented
in Table 1. Within the hypertensive and normotensive
groups, the mean levels of haemoglobin, HCT and RBC
were significantly higher in male compared to females
(p<0.05). However, the platelet level was higher in
female than in male (p<0.05). There were no significant
differences in the levels of WBC, MCV, MCH and
MCHC between males and female (p>0.05). While the
mean levels of haemoglobin, WBC and platelets were
significantly higher in the hypertensive group compared
to normotensive (p<0.05), there were no significant
differences between these two groups in the levels of
RBC, MCV, HCT, MCH and MCHC (p>0.05).
Hypertensive individuals had significantly higher mean
levels of glucose, Tc, LDL-c, HDL-c, triglycerides and
HbAIc compared to normotensive individuals, while
there were no significant differences in the mean levels
of Apo AI and Apo B. However, there were variations
in the levels of certain parameters between male and
female within the hypertensive and the normotensive
groups. The most striking difference was in the level
of Tg where the male had a signicantly higher mean
Tg level compared to female in both groups.
Table 1
CBC (Mean ± SD) of normotensive controls and hypertensive groups
Gender WBC RBC Haemoglobin HCT MCV MCH MCHC PLT
(109/L) (1012/L) (g/dl) (%) (fl) (pg) (g/dl) (109/L)
Controls
 Male 5.64±1.53 5.08±0.59 13.74±1.44 39.99±3.57 79.20±7.36 27.16±3.30 34.18±1.23 237.8±57.7
 Female 5.64±1.55 4.49±0.55 11.77±1.30 34.78±3.18 77.66±8.39 26.63±3.82 33.99±1.31 275.90±69.1
 Total 5.64±1.54 4.82±0.65 12.84±1.69 37.70±4.27 78.52±7.85 26.93±3.54 34.10±1.27 254.6±65.7
Hypertensives
 Male 6.41±1.17 5.04±0.48 14.26±1.38 41.91±3.50 83.55±6.53 28.43±2.70 34.10±1.04 264.53±64.8
 Female 6.42±1.44 4.59±0.49 12.18±1.27 36.43±3.66 79.40±7.74 26.58±3.16 33.45±0.99 288.0±75.4
 Total 6.42±1.45 4.79±0.53 13.11±1.67 38.83±4.50 81.23±7.51 27.40±3.04 33.73±1.05 277.7±71.7
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Table 2
Serum lipid profile, glucose and HbAIc of the two study groups (Mean ± SD)
Test Parameters Controls Hypertensives
Male Female Total Male Female Total
Glucose (mg/dL) 93.84±47.8 89.1±42.7 91.15±45.3 136.5±60.5 122.5±52.0 128.8±56.3
TC (mg/dL) 168.8±30.64 176.4±38.63 172.7±34.88 196.7±33.46 195.7±40.18 196.1±37.24
LDL-c (mg/dL) 105.8±25.6 114.1±30.5 109.8±28.3 126.7±33.4 131.4±36.7 129.2±35.2
Tg (mg/dL) 104.8±67.2 89.4±55.3 97.4±62.2 145.2±76.9 119.4±68.2 131.0±73.2
HDL-g (mg/dL) 40.7±8.5 44.6±9.1 42.6±9.0 44.1±8.7 46.6±9.0 45.7±8.9
Apo Al (g/L) 1.53±0.35 1.63±0.36 1.58±0.36 1.45±0.31 1.60±0.55 1.52±0.44
Apo B (g/L) 1.05±0.33 1.00±0.32 1.03±0.32 1.06±0.24 0.93±0.32 1.0±0.29
HbAlc (%) 7.48±2.24 7.45±2.4 7.47±2.31 8.99±2.98 8.93±2.3 8.96±2.3
Table 3
Serum Electrolyte, BUN, creatinine and uric acid levels of the two study groups (Mean ± SD)
Normotensive Controls Hypertensives
Test parameters Male Female Total Male Female Total
Sodium (meq/L) 132.8±13.5 131.5±12.1 132.1±12.8 138.3±6.1 137.80±8.5 138.00±7.5
Potassium (meq/L) 4.75±0.63 4.61±0.53 4.68±0.59 4.34±0.47 4.13±0.44 4.22±0.47
Chloride (meq/L) 98.2±8.2 97.1±7.6 97.7±7.9 101.6±5.0 102.4±4.6 102.0±4.8
Calcium (mg/dL) 9.15±1.11 9.28±0.97 9.21±1.05 9.61±0.82 9.42±1.02 9.51±0.92
BUN (mg/dL) 26.58±8.15 24.29±7.43 25.44±7.90 21.03±11.62 14.50±7.29 17.50±10.05
Creatinine (mg/dL) 0.84±0.167 0.711±0.153 0.781±0.174 1.059±0.349 0.757±0.219 0.90±0.349
Uric acid (mg/dL) 5.85±1.48 4.61±1.21 5.26±1.49 5.65±1.23 4.66±1.48 5.12±1.45
Within the hypertensive and normotensive groups,
the mean levels of creatinine, BUN, uric acid and
potassium were significantly higher in male compared
to female (P<0.05). However, there were no significant
differences in the levels of sodium, calcium and
chloride (p>0.05) between male and female within
these two groups. While the mean levels of chloride,
sodium, calcium and creatinine were significantly higher
in the hypertensive group compared to normotensive
(p<0.05), there was no significant difference between
these two groups in the levels of uric acid (p>0.05).
Hypertensive individuals however had significantly
lower mean levels of potassium and BUN (p<0.05).
DISCUSSION
Abnormal lipid and lipoprotein levels are all
positively associated with an increased risk in the
incidence of CVD(21-23). In western Europe and the
USA, CVD is the leading cause of morbidity and
mortality with hypertension being the most common
cause with a prevalence above 20% in the general
population (24,25). In many developing countries,
serum lipid levels are low and the incidence of CVD
is less frequent when compared to western countries
(26). However, these populations are increasingly
exposed to urbanisation and associated changes in diet,
physical activity and life styles. As a consequence, a
CVD epidemic may be emerging due to an increase
in risk factors. In the past four decades, the kingdom
of Saudi Arabia has undergone profound socio-economic
changes due to rapid urbanisation and a large increase
in per capita income. This background suggests an
increased prevalence of CVD which prompted this
study (27). Information on CVD risk factors and
hypertension in the population of the Eastern Province
of Saudi Arabia is limited. Such information would
allow us to improve control of hypertension which may
contribute to a decrease in common causes of morbidity
and mortality. The procedure by which a cohort is
selected for any study is of fundamental importance for
the interpretation of the results obtained and their
accuracy. In the present study, which was part of a
population based cross-sectional household survey,
utmost care was taken to ensure the randomness of the
sample selected and that all criteria were strictly
dhered to. This broad coverage was needed for
variables of genetic identity, physical environment and
social and economical factors which were expected to
affect the results. Thus the design of the study was
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similar to those perfomed in the U.S and European
countries and therefore allows for meaningful
comparison.
Although a number of studies have shown
significant differences in the levels of haemoglobin,
RBC, MCV, HCT and MCH between hypertensive and
normotensive individuals, other studies have shown no
significant differences between these groups (28-32).
Our data do not show any significant differences in the
levels of these parameters between hypertensive and the
normotensive control group. However, the mean levels
of haemoglobin, WBC and platelets were significantly
higher in the hypertensive group compared to the
normotensive. Furthermore, it has to be emphasised that
there is a significant difference in the parameters
between the gender within each group. This is in
agreement with previous population based studies (33).
The present study shows that serum concentrations
of Tc, LDL-c, HDL-C, Tg, glucose and HbAI-c were
significantly higher in the hypertensive group compared
to controls. This was true not only among men but also
among women and is in close agreement with previous
reported data (6). High glucose and HbAIc levels are
a reflection of higher prevalence of diabetes mellitus
among hypertensives as compared to normotensives
(34). There is a relatively small but significant increase
in the level of HDL-c, which is an important measure
to compare across populations in hypertensive individuals
compared to normotensive counterparts and in female
compared to male. This conclusion is at variance with
an earlier study of HDL-c in Saudi male and female
(7). However, the observed higher levels of HDL-c in
women modifies the coronary heart disease risk factors
in this population. On comparison of lipid profile
results obtained with the results of the European or
American cohort, it is clear that Saudi populations in
the Eastern Province have on average a lower lipid
concentration. This can be reflected by the lower
prevalence of CVD (10%) (unpublised data) seen in
the region compared to European or American
populations (>20%)(35).
It has been well established that an increased level
of sodium and a decreased level of potassium is
associated with hypertension (36,37). Our data clearly
indicate that the hypertensive group has a higher level
of sodium and a lower level of potassium compared
with the control normotensive group. This is true in
other populations with a high prevalence of hypertension
which may be due to hypertensive medication (38). In
addition the data clearly indicate that hypertensive
individuals have a higher mean creatinine level compared
to normotensive individuals. This agrees with previous
published data for other populations. This suggests
some degree of renal impairment in this population. In
this regard, it is unusual that the blood urea nitrogen
was lower in hypertensives than in normotensives.
In conclusion, the present data have made an
important contribution in establishing base line values
of serum lipids in normal and hypertensive populations
in the Eastern Province. In addition, these data address
the feasibility of reducing the serum lipids of hypertensives
in order to reduce the prevalence of CVD.
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